Clinical trial Recruiting at 1 site Observational Ages 18 and up

Measuring lung overinflation with electrical impedance tomography in ventilated COPD patients

Official title: Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrom in Prone Position.

Run by Centre Hospitalier de la côte Basque · NCT07090460 · Data updated 2026-11-12

This project will use electrical impedance tomography to see if ventilated adults with moderate-to-severe COPD have uneven lung inflation or overdistension while on NIV or invasive ventilation.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorCentre Hospitalier de la côte Basque
Academic / other
Locations1 site (Bayonne, Centre Hospitalier de La Côte Basque)
StatusRecruiting
StartedNovember 22, 2025
Main results expectedAugust 2026
Study endsSeptember 2026
Registry record updatedJune 1, 2026
Trial IDNCT07090460 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) hospitalized in the ICU with moderate or severe COPD (GOLD 3–4) who are receiving NIV or invasive mechanical ventilation and can be fitted with an EIT belt are ideal candidates.

Probably not a fit

Patients with contraindications to EIT (for example pacemakers or implantable defibrillators), bronchopleural leaks, inability to position the EIT belt, pregnant or breastfeeding women, or those under guardianship are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll adults with moderate-to-severe COPD who require noninvasive or invasive mechanical ventilation and who can be monitored with an EIT belt. Continuous EIT recordings will be made during tidal ventilation and during clinician-directed PEEP titration; in intubated patients a low-flow pressure–volume maneuver with simultaneous EIT will be performed to derive one-lung PEEPi. Analyses will measure interlung insufflation delay and regional tidal distribution to detect asymmetry and overdistension between lungs. Data will be analyzed offline with dedicated software to reconstruct regional PV curves and estimate regional intrinsic PEEP.

Why it matters

Potential benefit: If successful, the findings could help clinicians detect asymmetric overinflation and ventilator asynchronies so they can better tailor ventilator settings and potentially reduce complications.

How similar studies have gone: Previous work has shown EIT can map regional ventilation and detect overdistension, but using EIT to measure one-lung PEEPi and interlung insufflation delay in COPD is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients hospitalized in the ICU and who suffered moderate or severe COP (Gold 3 and 4)), with respiratory acidosis under NIV or intubated, and equipped with EIT over the age of 18.

Exclusion Criteria:

* Broncho-pleural leaks
* Pregnant or breastfeeding woman.
* Guardianship or curatorship
* Deprived of liberty
* No health insurance
* Impossibility to correctly position the EIT belt (e.g., dressings, chest drainage, etc.)
* Contra indications to EIT (e.g., implantable cardiac defibrillator, pacemaker, instable spinal lesions)

Where it's running

  • Centre Hospitalier Côte Basque
    Bayonne, Centre Hospitalier de La Côte Basque, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.